Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

United Health Products (UEEC) Cash from Investing Activities (2020 - 2023)

United Health Products (UEEC) has disclosed Cash from Investing Activities for 4 consecutive years, with -$2850.0 as the latest value for Q2 2023.

  • On a quarterly basis, Cash from Investing Activities changed N/A to -$2850.0 in Q2 2023 year-over-year; TTM through Mar 2024 was -$2850.0, a N/A change, with the full-year FY2023 number at -$2850.0, up 92.96% from a year prior.
  • Cash from Investing Activities was -$2850.0 for Q2 2023 at United Health Products, up from -$40500.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$2850.0 in Q2 2023 to a low of -$87000.0 in Q2 2020.
  • A 3-year average of -$28940.0 and a median of -$9261.0 in 2020 define the central range for Cash from Investing Activities.